Alcohol Labeling Study
Launched by UNIVERSITY OF NORTH CAROLINA, CHAPEL HILL · Feb 14, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Alcohol Labeling Study is looking at how new health warnings on alcohol containers might affect how much people drink. In this study, participants will be randomly placed into two groups: one will see the new health warnings on their alcohol, while the other group will see standard labels. Participants will bring their own alcohol to the study visits and consume it as they usually would at home.
To join this study, you need to be at least 21 years old, drink alcohol at least once a week, and not have any issues with alcohol dependence. You'll also need to be able to attend three in-person visits and bring enough alcohol for those visits. Additionally, you should be comfortable taking surveys in English and responding to daily text messages for three weeks. This study is not yet recruiting, and it is important to note that only people living in the U.S. can participate.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults ages 21 years and older
- • Not identified as having possible alcohol dependence
- • Consumed alcohol at least once per week during the past 4 weeks
- • At least half of alcohol consumed each week is from store-bought containers
- • Willing to bring 8 days' worth of alcohol to 3 in-person study visits
- • Not pregnant, breastfeeding, or trying to get pregnant
- • Able to take surveys in English
- • Willing to respond to text messages daily for 3 weeks
- • Not living in the same household as anyone else in the study
- Exclusion Criteria:
- • - Not living in US
About University Of North Carolina, Chapel Hill
The University of North Carolina at Chapel Hill (UNC) is a leading research institution renowned for its commitment to advancing health and science through innovative clinical trials. With a robust infrastructure that supports multidisciplinary collaboration, UNC conducts cutting-edge research across various fields, including medicine, public health, and biomedical sciences. The university is dedicated to improving patient care and health outcomes by translating its research findings into practical applications. UNC’s clinical trials are designed to evaluate new therapies, interventions, and technologies, ensuring that they meet the highest ethical and scientific standards while fostering a culture of inclusivity and community engagement.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chapel Hill, North Carolina, United States
Chapel Hill, North Carolina, United States
Chapel Hill, North Carolina, United States
Patients applied
Trial Officials
Marissa Hall, PhD
Principal Investigator
University of North Carolina, Chapel Hill
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported